beta-lactams has been researched along with Intestinal Perforation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fernández, L; Gómez-Rice, A; Lillo, M; Maseda, E; Ramasco, F; Villagrán, MJ | 1 |
Mikamo, H; Shinagawa, N; Takesue, Y; Takeyama, H; Tanaka, K; Taniguchi, M; Watanabe, K; Yokoyama, T | 1 |
1 trial(s) available for beta-lactams and Intestinal Perforation
Article | Year |
---|---|
[Septic shock due to community-acquired complicated intra-abdominal infection treated with ertapenem: outcome in 25 cases].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Critical Care; Emergencies; Ertapenem; Female; Hospital Mortality; Humans; Intestinal Perforation; Length of Stay; Male; Middle Aged; Peritonitis; Prospective Studies; Shock, Septic; Survival Analysis; Treatment Outcome | 2008 |
1 other study(ies) available for beta-lactams and Intestinal Perforation
Article | Year |
---|---|
[Bacteria isolated from perforation peritonitis and their antimicrobial susceptibilities].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intestinal Perforation; Male; Middle Aged; Peritonitis | 2007 |